Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Mesa Laboratories ( (MLAB) ) has provided an announcement.
On March 9, 2026, Mesa Laboratories announced that long‑time President and CEO Gary Owens, who has led the company since 2017 through significant growth and market expansion, will step down on April 12, 2026. The board emphasized that his departure is amicable and not related to any disagreement over operations, policies or practices, and the terms of his separation are still being finalized.
To lead the company’s next phase, Mesa’s board appointed life sciences veteran Dr. Siddhartha Kadia as President, CEO and director, effective April 13, 2026, following a comprehensive external succession process. His compensation package includes an $850,000 base salary, performance‑linked cash incentives, and sizable time‑ and performance‑vested equity awards, underscoring the board’s intent to leverage his experience scaling global life science businesses to drive Mesa’s long‑term growth and strategic execution.
The most recent analyst rating on (MLAB) stock is a Hold with a $100.00 price target. To see the full list of analyst forecasts on Mesa Laboratories stock, see the MLAB Stock Forecast page.
Spark’s Take on MLAB Stock
According to Spark, TipRanks’ AI Analyst, MLAB is a Neutral.
The score is primarily supported by strong and improving cash generation and healthy operating-level profitability, but is held back by unstable net earnings/returns (negative P/E and weak ROE) and mixed-to-weak technical momentum (negative MACD and price below key moving averages).
To see Spark’s full report on MLAB stock, click here.
More about Mesa Laboratories
Mesa Laboratories, Inc., based in Lakewood, Colorado, is a global leader in the design and manufacture of life science tools and critical quality control solutions. The company provides products and services for regulated applications in the pharmaceutical, healthcare and medical device industries, helping customers ensure product integrity, enhance safety, and improve quality of life worldwide.
Average Trading Volume: 96,916
Technical Sentiment Signal: Sell
Current Market Cap: $481M
For detailed information about MLAB stock, go to TipRanks’ Stock Analysis page.